Your browser doesn't support javascript.
loading
Mass spectrometry-based multi-attribute method for mutation analysis in the early development of therapeutic proteins.
Liu, Tao; Li, Yantao; Xu, Jin; Guo, Qingcheng; Zhu, Lei; Fu, Tuo; Li, Jun; Zhang, Dapeng; Qian, Weizhu; Zhou, Xinli; Guo, Huaizu; Hou, Sheng.
Afiliação
  • Liu T; Department of Oncology, Huashan Hospital, Fudan University, Shanghai, China; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai, China.
  • Li Y; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai, China.
  • Xu J; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai, China; School of Pharmaceutical Sciences, Liaocheng University, Liaocheng, China; Shanghai Zhangjiang Biotechnology Co., Ltd, Shang
  • Guo Q; Taizhou Mabtech Pharmaceuticals Co., Ltd, Taizhou, China.
  • Zhu L; Department of Nucleus Radiation-related Injury Treatment, PLA Rocket Force Characteristic Medical Center, Beijing, China.
  • Fu T; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai, China.
  • Li J; School of Pharmaceutical Sciences, Liaocheng University, Liaocheng, China.
  • Zhang D; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai, China; School of Pharmaceutical Sciences, Liaocheng University, Liaocheng, China.
  • Qian W; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai, China; School of Pharmaceutical Sciences, Liaocheng University, Liaocheng, China.
  • Zhou X; Department of Oncology, Huashan Hospital, Fudan University, Shanghai, China. Electronic address: xinli_zhou73@163.com.
  • Guo H; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai, China; School of Pharmaceutical Sciences, Liaocheng University, Liaocheng, China; Shanghai Zhangjiang Biotechnology Co., Ltd, Shang
  • Hou S; State Key Laboratory of Antibody Medicine and Targeted Therapy, Shanghai, China; NMPA Key Laboratory for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai, China; School of Pharmaceutical Sciences, Liaocheng University, Liaocheng, China. Electronic address: housheng301@163.com.
J Pharm Biomed Anal ; 220: 115018, 2022 Oct 25.
Article em En | MEDLINE | ID: mdl-36030755
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espectrometria de Massas em Tandem / Anticorpos Monoclonais Idioma: En Revista: J Pharm Biomed Anal Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espectrometria de Massas em Tandem / Anticorpos Monoclonais Idioma: En Revista: J Pharm Biomed Anal Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China